Jump to ContentJump to Main Navigation
Handbook of Cannabis$
Users without a subscription are not able to see the full content.

Roger Pertwee

Print publication date: 2014

Print ISBN-13: 9780199662685

Published to Oxford Scholarship Online: January 2015

DOI: 10.1093/acprof:oso/9780199662685.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2020. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 31 October 2020

Cardiovascular, Metabolic, Liver, Kidney, and Inflammatory Disorders

Cardiovascular, Metabolic, Liver, Kidney, and Inflammatory Disorders

Chapter:
(p.564) Chapter 31 Cardiovascular, Metabolic, Liver, Kidney, and Inflammatory Disorders
Source:
Handbook of Cannabis
Author(s):

Pál Pacher

George Kunos

Publisher:
Oxford University Press
DOI:10.1093/acprof:oso/9780199662685.003.0031

There is increasing evidence that phytocannabinoids may exert beneficial effects in inflammatory, cardiovascular, metabolic, liver, and kidney disorders. This chapter briefly discusses the potential therapeutic targets and applications of phytocannabinoids, primarily based on in vivo studies. The focus is on the therapeutic effects of cannabidiol (CBD), the most abundant non-psychotropic constituent of Cannabis sativa (marijuana), and on the therapeutic and undesirable effects of Δ‎9-tetrahydrocannabinol (THC), the psychoactive constituent of marijuana initially thought to be responsible for the whole spectrum of the biological effects of marijuana. The therapeutic potential of Δ‎9-tetrahydrocannabivarin (Δ‎9THCV), a natural cannabinoid found in marijuana plant, and (E)-β‎-caryophyllene (BCP; FDA-approved food additive), a natural sesquiterpene found in many essential oils of spice including in Cannabis sativa, will also be highlighted based on several recent studies.

Keywords:   phytocannabinoids, Δ9-tetrahydrocannabivarin, Δ9-tetrahydrocannabinol, cannabidiol, (E)-β-caryophyllene, inflammatory, cardiovascular, metabolic, liver, kidney

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .